title: G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets.
abstract: G-proteins are important mediators of hormonal inhibition of insulin secretion. To characterize the pertussis toxin-sensitive substrates present in HIT cell membranes, we performed immunoblots with specific antisera and found evidence for the presence of Gi alpha 1, Gi alpha 2, Gi alpha 3, and three forms of Go alpha. We observed that pertussis toxin-sensitive substrates mediate all of the effects of SRIF, and a major portion of the effects of EPI, on insulin secretion from rat islets during static incubations. These results agree with our previously reported studies examining phasic glucose-induced insulin secretion from HIT cells. To ascertain whether inhibition of adenylate cyclase, presumably involving coupling of the catalytic subunit to Gi, may be a common mechanism for both hormones, we studied the effects of 8-bromo-cyclic AMP and found that this agent partially prevented the inhibitory effects of both hormones. We also observed that the inhibitory effects of SRIF and EPI on insulin were nonadditive, that both hormones were additive to nickel chloride during inhibition of insulin release, and that they noncompetitively inhibited glipizide-induced insulin secretion through pertussis toxin-sensitive mechanisms. Together, these results suggest that both hormones exert their effects on insulin secretion at multiple G-protein-regulated sites including adenylate cyclase and sites distal to the glipizide-binding site on the KATP channel.
authors.affiliation: Department of Medicine, University of Minnesota, Minneapolis 55455.
authors.forename: E R
authors.initials: ER
authors.lastname: Seaquist
authors.forename: A R
authors.initials: AR
authors.lastname: Neal
authors.forename: K D
authors.initials: KD
authors.lastname: Shoger
authors.forename: T F
authors.initials: TF
authors.lastname: Walseth
authors.forename: R P
authors.initials: RP
authors.lastname: Robertson
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000246:Adenosine Diphosphate Ribose / Q000378:metabolism; D037361:Adenylate Cyclase Toxin; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D004837:Epinephrine / Q000494:pharmacology*; D019204:GTP-Binding Proteins / Q000302:isolation & purification / Q000378:metabolism*; D005913:Glipizide / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology*; D066298:In Vitro Techniques; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008647:Mesocricetus; D008954:Models, Biological; D009243:NAD / Q000378:metabolism; D037342:Pertussis Toxin; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000494:pharmacology*; D010566:Virulence Factors, Bordetella / Q000494:pharmacology*
chemical_list: D037361:Adenylate Cyclase Toxin; D010566:Virulence Factors, Bordetella; D009243:NAD; D000246:Adenosine Diphosphate Ribose; D015124:8-Bromo Cyclic Adenosine Monophosphate; D013004:Somatostatin; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D005947:Glucose; D015056:1-Methyl-3-isobutylxanthine; D005913:Glipizide; D004837:Epinephrine